WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and former Shake Shack executive,
Oprah Winfrey’s body has been scrutinized at her biggest and smallest — no matter her influence. Here is how to counter the ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Jon Gosselin detailed the ebbs and flows of his weight-loss journey, which included semaglutide and weight gain, but he's ...
The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here ...
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
If you're looking to lose weight, the Zone Diet, created by Dr. Barry Sears, may be worth checking out. A dietitian shares ...
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...
Obesity is a global health crisis, increasing the risk of chronic conditions like diabetes, heart disease, and metabolic ...
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback